The global health governance of antimicrobial effectiveness
2006
Addressing Antimicrobial Resistance Globally
Editorial
Author Information
Author(s): Martin Greg
Primary Institution: London School of Hygiene and Tropical Medicine
Hypothesis
How can global health governance effectively combat antimicrobial resistance?
Conclusion
Global health governance strategies must focus on incentivizing drug development, promoting responsible antimicrobial use, and enhancing surveillance to combat antimicrobial resistance.
Supporting Evidence
- Antimicrobial resistance is a growing threat to public health worldwide.
- Public Private Partnerships have shown promise in incentivizing drug development.
- Responsible antimicrobial usage by clinicians is crucial to combat resistance.
Takeaway
Antimicrobial resistance is a big problem that needs everyone to work together to make sure we use medicines wisely and keep track of how they are working.
Potential Biases
Overuse of antimicrobials is influenced by patient demands in private healthcare.
Limitations
The pace of research and development for diseases affecting the poorest countries is lacking.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website